Skip to main content

Advertisement

SpringerLink
Log in

Have Molecularly Targeted Therapies Improved Overall Survival in Renal Cell Carcinoma?

  • Clinical Trial Report
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115–24.

    Article  PubMed  CAS  Google Scholar 

  2. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125–34.

    Article  PubMed  CAS  Google Scholar 

  3. Motzer RJ, Escudier B, Oudard S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372:449–56.

    Article  PubMed  CAS  Google Scholar 

  4. C. N. Sternberg CS, E. Lee, P. V. Salman, J. Mardiak, I. D. Davis, L. Pandite, M. Chen, L. McCann, R. Hawkins. A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC). J Clin Oncol. 2009;27

  5. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356:2271–81.

    Article  PubMed  CAS  Google Scholar 

  6. Escudier B, Pluzanska A, Koralewski P, et al. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet. 2007;370:2103–11.

    Article  PubMed  Google Scholar 

  7. Rini BI, Halabi S, Rosenberg JE, et al. Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206. J Clin Oncol. 2008;26:5422–8.

    Article  PubMed  CAS  Google Scholar 

  8. Escudier B, Eisen T, Stadler WM, et al. Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol. 2009;27:3312–8.

    Article  PubMed  CAS  Google Scholar 

  9. Motzer RJ, Escudier B, Oudard S, et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors. Cancer. 2010;116(18):4256–65.

    Google Scholar 

  10. Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009;27:3584–90.

    Article  PubMed  CAS  Google Scholar 

  11. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20:289–96.

    Article  PubMed  CAS  Google Scholar 

  12. Di Lorenzo G, Buonerba C. Kidney cancer: overall survival is an unsuitable primary end point. Nat Rev Urol. 2010;7:367–68.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of GU Medical Oncology, 1515 Holcombe, Houston, TX, 77030, USA

    Michel Choueiri & Eric Jonasch

Authors
  1. Michel Choueiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Jonasch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Jonasch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choueiri, M., Jonasch, E. Have Molecularly Targeted Therapies Improved Overall Survival in Renal Cell Carcinoma?. Curr Oncol Rep 13, 153–156 (2011). https://doi.org/10.1007/s11912-011-0167-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-011-0167-y

Keywords

Search

Navigation